Neurocrine Biosciences
NBIX
#1377
Rank
NZ$27.85 B
Marketcap
NZ$275.24
Share price
-3.84%
Change (1 day)
11.48%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company